XML 91 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EQUITY BASED COMPENSATION - Narrative (Details)
$ in Millions
1 Months Ended 12 Months Ended
Apr. 11, 2023
Apr. 30, 2023
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
Oct. 31, 2022
shares
Feb. 28, 2021
shares
Disclosure Of Compensation Related Costs Sharebased Payments [Line Items]            
Conversion ratio   2        
Granted (in shares)     100,000      
Vesting period     3 years      
Share based compensation arrangement, expiration period     10 years      
Stock-based compensation expense | $     $ 2.3 $ 2.6    
Class A Common Stock            
Disclosure Of Compensation Related Costs Sharebased Payments [Line Items]            
Number of shares registered (in shares)         307,684  
Conversion ratio 0.1          
Restricted stock awards            
Disclosure Of Compensation Related Costs Sharebased Payments [Line Items]            
Shares based payment arrangement, equity instrument other than option, granted in period (in shares)     33,418      
Shares based payment arrangement, equity instrument other than option, vested in period (in shares)     48,548      
Fair market value of the awards granted | $     $ 0.2 0.7    
Unrecognized compensation cost | $     $ 0.1      
Weighted average vesting period     1 year      
Options            
Disclosure Of Compensation Related Costs Sharebased Payments [Line Items]            
Fair market value of award, options granted | $     $ 0.5 $ 3.1    
Unrecognized compensation cost | $     $ 2.4      
Weighted average vesting period     2 years 1 month 6 days      
2021 Equity Plan            
Disclosure Of Compensation Related Costs Sharebased Payments [Line Items]            
Common stock reserved for issuance (in shares)   883,111       383,111
Number of additional shares authorized (in shares)   500,000        
Shares issued (in shares)     0      
2021 Equity Plan | Restricted stock awards            
Disclosure Of Compensation Related Costs Sharebased Payments [Line Items]            
Shares based payment arrangement, equity instrument other than option, granted in period (in shares)     33,418      
Vesting period     3 years      
Shares based payment arrangement, vesting rights percentage     33.30%      
2021 Equity Plan | Restricted stock awards | Former Chief Executive Officer            
Disclosure Of Compensation Related Costs Sharebased Payments [Line Items]            
Vesting period     84 days